← Leaderboards
Vivienne Margaret Jackson
Byomass, Inc.
$354,845
Attributed
$354,845
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $299.8K · FY2019–20$500K$375K$250K$125K$0
'19
'20
Funding mix
By agency
NIH$354,845 · 1
By mechanism
R43$354,845 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAgonistAnalogAnorexiaAntibodiesAppetite LossBaseBindingBiologicalBody Weight DecreasedBrainBrain StemCachexiaCancer AnorexiaCancer CachexiaCancer EtiologyCancer ModelCancer PatientCancer TherapyCatabolismChemistryChemotherapyClinical CandidateAdvanced Malignant Neoplasm
Grant awards (2)
Identification of first in class small molecule GFRAL blockers for the prevention and reversal of Cancer Anorexia-Cachexia$55,000
R43 · FY2020 · CA · contact PI
Identification of first in class small molecule GFRAL blockers for the prevention and reversal of Cancer Anorexia-Cachexia$299,845
R43 · FY2019 · CA · contact PI